Get started
Work

Influence of Age on Efficacy and Safety of Sacubitril/valsartan in Heart Failure With Preserved Ejection Fraction

Year: 2020
Type: article
Abstract: Background: Heart failure with preserved ejection fraction (HFpEF) disproportionately affects older adults, who may have different risk/benefit profiles to medications. Methods: We assessed efficacy, safety, medication dose, and discontinuation by age continuously and categorically (< 65, 65-74,
DOI: 10.1016/s0735-1097(20)31537-0
Authors: Orly Vardeny, Brian Claggett, Inderjit Anand, Muthiah Vaduganathan, Marc A. Pfeffer, Faiez Zannad, Aldo Pietro Maggioni, Margaret M. Redfield, Milton Packer, Akshay S. Desai, John Cleland, Gerasimos S. Filippatos, Sanjiv Shah, John McMurray, Scott D. Solomon
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W3012202183
FWCI: 0.313
Cites:
Cited by: 2
Related to: 10